According to this latest study, the 2021 growth of Antidote will have significant change from previous year. By the most conservative estimates of global Antidote market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 8453.5 million in 2020. Over the next five years the Antidote market will register a 3.2% CAGR in terms of revenue, the global market size will reach US$ 9594.5 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Antidote market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Chemical Antidotes

Physical Antidotes

Pharmacological Antidotes

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Pesticide Poisoning

Heavy Metal Poisoning

Animal Bites Poisoning

Cyanide Poisoning

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Roche

Pfizer

Bayer

Johnson & Johnson

Novartis

Eli Lilly

Teva

Boehringer Ingelheim

Mylan

Fresenius Kabi

Baxter

Furen Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antidote Market Size 2016-2026

2.1.2 Antidote Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Antidote Segment by Type

2.2.1 Chemical Antidotes

2.2.2 Chemical Antidotes

2.2.3 Pharmacological Antidotes

2.3 Antidote Market Size by Type

2.3.1 Global Antidote Market Size CAGR by Type

2.3.2 Global Antidote Market Size Market Share by Type (2016-2021)

2.4 Antidote Segment by Application

2.4.1 Pesticide Poisoning

2.4.2 Heavy Metal Poisoning

2.4.3 Animal Bites Poisoning

2.4.4 Cyanide Poisoning

2.4.5 Others

2.5 Antidote Market Size by Application

2.5.1 Global Antidote Market Size CAGR by Application

2.5.2 Global Antidote Market Size Market Share by Application (2016-2021)

3 Antidote Market Size by Players

3.1 Antidote Market Size Market Share by Players

3.1.1 Global Antidote Revenue by Players (2019-2021E)

3.1.2 Global Antidote Revenue Market Share by Players (2019-2021E)

3.2 Global Antidote Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Antidote by Regions

4.1 Antidote Market Size by Regions (2016-2021)

4.2 Americas Antidote Market Size Growth (2016-2021)

4.3 APAC Antidote Market Size Growth (2016-2021)

4.4 Europe Antidote Market Size Growth (2016-2021)

4.5 Middle East & Africa Antidote Market Size Growth (2016-2021)

5 Americas

5.1 Americas Antidote Market Size by Country (2016-2021)

5.2 Americas Antidote Market Size by Type (2016-2021)

5.3 Americas Antidote Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antidote Market Size by Region (2016-2021)

6.2 APAC Antidote Market Size by Type (2016-2021)

6.3 APAC Antidote Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Antidote by Country (2016-2021)

7.2 Europe Antidote Market Size by Type (2016-2021)

7.3 Europe Antidote Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antidote by Region (2016-2021)

8.2 Middle East & Africa Antidote Market Size by Type (2016-2021)

8.3 Middle East & Africa Antidote Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Antidote Market Forecast

10.1 Global Antidote Forecast by Regions (2021-2026)

10.1.1 Global Antidote Forecast by Regions (2021-2026)

10.1.2 Americas Antidote Forecast

10.1.3 APAC Antidote Forecast

10.1.4 Europe Antidote Forecast

10.1.5 Middle East & Africa Antidote Forecast

10.2 Americas Antidote Forecast by Countries (2021-2026)

10.2.1 United States Antidote Market Forecast

10.2.2 Canada Antidote Market Forecast

10.2.3 Mexico Antidote Market Forecast

10.2.4 Brazil Antidote Market Forecast

10.3 APAC Antidote Forecast by Region (2021-2026)

10.3.1 China Antidote Market Forecast

10.3.2 Japan Antidote Market Forecast

10.3.3 Korea Antidote Market Forecast

10.3.4 Southeast Asia Antidote Market Forecast

10.3.5 India Antidote Market Forecast

10.3.6 Australia Antidote Market Forecast

10.4 Europe Antidote Forecast by Country (2021-2026)

10.4.1 Germany Antidote Market Forecast

10.4.2 France Antidote Market Forecast

10.4.3 UK Antidote Market Forecast

10.4.4 Italy Antidote Market Forecast

10.4.5 Russia Antidote Market Forecast

10.5 Middle East & Africa Antidote Forecast by Region (2021-2026)

10.5.1 Egypt Antidote Market Forecast

10.5.2 South Africa Antidote Market Forecast

10.5.3 Israel Antidote Market Forecast

10.5.4 Turkey Antidote Market Forecast

10.5.5 GCC Countries Antidote Market Forecast

10.6 Global Antidote Forecast by Type (2021-2026)

10.8 Global Antidote Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Antidote Product Offered

11.1.3 Roche Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Antidote Product Offered

11.2.3 Pfizer Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Pfizer Main Business Overview

11.2.5 Pfizer Latest Developments

11.3 Bayer

11.3.1 Bayer Company Information

11.3.2 Bayer Antidote Product Offered

11.3.3 Bayer Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Bayer Main Business Overview

11.3.5 Bayer Latest Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Information

11.4.2 Johnson & Johnson Antidote Product Offered

11.4.3 Johnson & Johnson Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Johnson & Johnson Main Business Overview

11.4.5 Johnson & Johnson Latest Developments

11.5 Novartis

11.5.1 Novartis Company Information

11.5.2 Novartis Antidote Product Offered

11.5.3 Novartis Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Novartis Main Business Overview

11.5.5 Novartis Latest Developments

11.6 Eli Lilly

11.6.1 Eli Lilly Company Information

11.6.2 Eli Lilly Antidote Product Offered

11.6.3 Eli Lilly Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Eli Lilly Main Business Overview

11.6.5 Eli Lilly Latest Developments

11.7 Teva

11.7.1 Teva Company Information

11.7.2 Teva Antidote Product Offered

11.7.3 Teva Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Teva Main Business Overview

11.7.5 Teva Latest Developments

11.8 Boehringer Ingelheim

11.8.1 Boehringer Ingelheim Company Information

11.8.2 Boehringer Ingelheim Antidote Product Offered

11.8.3 Boehringer Ingelheim Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Boehringer Ingelheim Main Business Overview

11.8.5 Boehringer Ingelheim Latest Developments

11.9 Mylan

11.9.1 Mylan Company Information

11.9.2 Mylan Antidote Product Offered

11.9.3 Mylan Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Mylan Main Business Overview

11.9.5 Mylan Latest Developments

11.10 Fresenius Kabi

11.10.1 Fresenius Kabi Company Information

11.10.2 Fresenius Kabi Antidote Product Offered

11.10.3 Fresenius Kabi Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Fresenius Kabi Main Business Overview

11.10.5 Fresenius Kabi Latest Developments

11. Baxter

11.11.1 Baxter Company Information

11.11.2 Baxter Antidote Product Offered

11.11.3 Baxter Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Baxter Main Business Overview

11.11.5 Baxter Latest Developments

11.12 Furen Pharmaceutical

11.12.1 Furen Pharmaceutical Company Information

11.12.2 Furen Pharmaceutical Antidote Product Offered

11.12.3 Furen Pharmaceutical Antidote Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Furen Pharmaceutical Main Business Overview

11.12.5 Furen Pharmaceutical Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Antidote Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Chemical Antidotes

Table 3. Major Players of Physical Antidotes

Table 4. Major Players of Pharmacological Antidotes

Table 5. Antidote Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 6. Global Antidote Market Size by Type (2016-2021) & ($ Millions)

Table 7. Global Antidote Market Size Market Share by Type (2016-2021)

Table 8. Antidote Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 9. Global Antidote Market Size by Application (2016-2021) & ($ Millions)

Table 10. Global Antidote Market Size Market Share by Application (2016-2021)

Table 11. Global Antidote Revenue by Players (2019-2021E) & ($ Millions)

Table 12. Global Antidote Revenue Market Share by Players (2019-2021E)

Table 13. Antidote Key Players Head office and Products Offered

Table 14. Antidote Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Antidote Market Size by Regions 2016-2021 & ($ Millions)

Table 18. Global Antidote Market Size Market Share by Regions 2016-2021

Table 19. Americas Antidote Market Size by Country (2016-2021) & ($ Millions)

Table 20. Americas Antidote Market Size Market Share by Country (2016-2021)

Table 21. Americas Antidote Market Size by Type (2016-2021) & ($ Millions)

Table 22. Americas Antidote Market Size Market Share by Type (2016-2021)

Table 23. Americas Antidote Market Size by Application (2016-2021) & ($ Millions)

Table 24. Americas Antidote Market Size Market Share by Application (2016-2021)

Table 25. APAC Antidote Market Size by Region (2016-2021) & ($ Millions)

Table 26. APAC Antidote Market Size Market Share by Region (2016-2021)

Table 27. APAC Antidote Market Size by Type (2016-2021) & ($ Millions)

Table 28. APAC Antidote Market Size Market Share by Type (2016-2021)

Table 29. APAC Antidote Market Size by Application (2016-2021) & ($ Millions)

Table 30. APAC Antidote Market Size Market Share by Application (2016-2021)

Table 31. Europe Antidote Market Size by Country (2016-2021) & ($ Millions)

Table 32. Europe Antidote Market Size Market Share by Country (2016-2021)

Table 33. Europe Antidote Market Size by Type (2016-2021) & ($ Millions)

Table 34. Europe Antidote Market Size Market Share by Type (2016-2021)

Table 35. Europe Antidote Market Size by Application (2016-2021) & ($ Millions)

Table 36. Europe Antidote Market Size Market Share by Application (2016-2021)

Table 37. Middle East & Africa Antidote Market Size by Region (2016-2021) & ($ Millions)

Table 38. Middle East & Africa Antidote Market Size Market Share by Region (2016-2021)

Table 39. Middle East & Africa Antidote Market Size by Type (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Antidote Market Size Market Share by Type (2016-2021)

Table 41. Middle East & Africa Antidote Market Size by Application (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Antidote Market Size Market Share by Application (2016-2021)

Table 43. Key and Potential Regions of Antidote

Table 44. Key Application and Potential Industries of Antidote

Table 45. Key Challenges of Antidote

Table 46. Key Trends of Antidote

Table 47. Global Antidote Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 48. Global Antidote Market Size Market Share Forecast by Regions (2021-2026)

Table 49. Global Antidote Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 50. Global Antidote Market Size Market Share Forecast by Type (2021-2026)

Table 51. Global Antidote Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 52. Global Antidote Market Size Market Share Forecast by Application (2021-2026)

Table 53. Roche Details, Company Type, Antidote Area Served and Its Competitors

Table 54. Roche Antidote Product Offered

Table 55. Roche Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 56. Roche Main Business

Table 57. Roche Latest Developments

Table 58. Pfizer Details, Company Type, Antidote Area Served and Its Competitors

Table 59. Pfizer Antidote Product Offered

Table 60. Pfizer Main Business

Table 61. Pfizer Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 62. Pfizer Latest Developments

Table 63. Bayer Details, Company Type, Antidote Area Served and Its Competitors

Table 64. Bayer Antidote Product Offered

Table 65. Bayer Main Business

Table 66. Bayer Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 67. Bayer Latest Developments

Table 68. Johnson & Johnson Details, Company Type, Antidote Area Served and Its Competitors

Table 69. Johnson & Johnson Antidote Product Offered

Table 70. Johnson & Johnson Main Business

Table 71. Johnson & Johnson Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 72. Johnson & Johnson Latest Developments

Table 73. Novartis Details, Company Type, Antidote Area Served and Its Competitors

Table 74. Novartis Antidote Product Offered

Table 75. Novartis Main Business

Table 76. Novartis Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 77. Novartis Latest Developments

Table 78. Eli Lilly Details, Company Type, Antidote Area Served and Its Competitors

Table 79. Eli Lilly Antidote Product Offered

Table 80. Eli Lilly Main Business

Table 81. Eli Lilly Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 82. Eli Lilly Latest Developments

Table 83. Teva Details, Company Type, Antidote Area Served and Its Competitors

Table 84. Teva Antidote Product Offered

Table 85. Teva Main Business

Table 86. Teva Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 87. Teva Latest Developments

Table 88. Boehringer Ingelheim Details, Company Type, Antidote Area Served and Its Competitors

Table 89. Boehringer Ingelheim Antidote Product Offered

Table 90. Boehringer Ingelheim Main Business

Table 91. Boehringer Ingelheim Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 92. Boehringer Ingelheim Latest Developments

Table 93. Mylan Details, Company Type, Antidote Area Served and Its Competitors

Table 94. Mylan Antidote Product Offered

Table 95. Mylan Main Business

Table 96. Mylan Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 97. Mylan Latest Developments

Table 98. Fresenius Kabi Details, Company Type, Antidote Area Served and Its Competitors

Table 99. Fresenius Kabi Antidote Product Offered

Table 100. Fresenius Kabi Main Business

Table 101. Fresenius Kabi Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 102. Fresenius Kabi Latest Developments

Table 103. Baxter Details, Company Type, Antidote Area Served and Its Competitors

Table 104. Baxter Antidote Product Offered

Table 105. Baxter Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 106. Baxter Main Business

Table 107. Baxter Latest Developments

Table 108. Furen Pharmaceutical Details, Company Type, Antidote Area Served and Its Competitors

Table 109. Furen Pharmaceutical Antidote Product Offered

Table 110. Furen Pharmaceutical Main Business

Table 111. Furen Pharmaceutical Antidote Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 112. Furen Pharmaceutical Latest Developments

List of Figures

Figure 1. Antidote Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Antidote Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Antidote Market Size Market Share by Type in 2020

Figure 7. Antidote in Pesticide Poisoning

Figure 8. Global Antidote Market: Pesticide Poisoning (2016-2021) & ($ Millions)

Figure 9. Antidote in Heavy Metal Poisoning

Figure 10. Global Antidote Market: Heavy Metal Poisoning (2016-2021) & ($ Millions)

Figure 11. Antidote in Animal Bites Poisoning

Figure 12. Global Antidote Market: Animal Bites Poisoning (2016-2021) & ($ Millions)

Figure 13. Antidote in Cyanide Poisoning

Figure 14. Global Antidote Market: Cyanide Poisoning (2016-2021) & ($ Millions)

Figure 15. Antidote in Others

Figure 16. Global Antidote Market: Others (2016-2021) & ($ Millions)

Figure 17. Global Antidote Market Size Market Share by Application in 2020

Figure 18. Global Antidote Revenue Market Share by Player in 2020

Figure 19. Global Antidote Market Size Market Share by Regions (2016-2021)

Figure 20. Americas Antidote Market Size 2016-2021 ($ Millions)

Figure 21. APAC Antidote Market Size 2016-2021 ($ Millions)

Figure 22. Europe Antidote Market Size 2016-2021 ($ Millions)

Figure 23. Middle East & Africa Antidote Market Size 2016-2021 ($ Millions)

Figure 24. Americas Antidote Market Size Market Share by Country in 2020

Figure 25. Americas Antidote Market Size Market Share by Type in 2020

Figure 26. Americas Antidote Market Size Market Share by Application in 2020

Figure 27. United States Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 28. Canada Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 29. Mexico Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 30. APAC Antidote Market Size Market Share by Regions in 2020

Figure 31. APAC Antidote Market Size Market Share by Type in 2020

Figure 32. APAC Antidote Market Size Market Share by Application in 2020

Figure 33. China Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 34. Japan Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 35. Korea Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 36. Southeast Asia Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 37. India Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 38. Australia Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 39. Europe Antidote Market Size Market Share by Country in 2020

Figure 40. Europe Antidote Market Size Market Share by Type in 2020

Figure 41. Europe Antidote Market Size Market Share by Application in 2020

Figure 42. Germany Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 43. France Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 44. UK Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 45. Italy Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 46. Russia Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Antidote Market Size Market Share by Region in 2020

Figure 48. Middle East & Africa Antidote Market Size Market Share by Type in 2020

Figure 49. Middle East & Africa Antidote Market Size Market Share by Application in 2020

Figure 50. Egypt Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 51. South Africa Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 52. Israel Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 53. Turkey Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 54. GCC Country Antidote Market Size Growth 2016-2021 ($ Millions)

Figure 55. Americas Antidote Market Size 2021-2026 ($ Millions)

Figure 56. APAC Antidote Market Size 2021-2026 ($ Millions)

Figure 57. Europe Antidote Market Size 2021-2026 ($ Millions)

Figure 58. Middle East & Africa Antidote Market Size 2021-2026 ($ Millions)

Figure 59. United States Antidote Market Size 2021-2026 ($ Millions)

Figure 60. Canada Antidote Market Size 2021-2026 ($ Millions)

Figure 61. Mexico Antidote Market Size 2021-2026 ($ Millions)

Figure 62. Brazil Antidote Market Size 2021-2026 ($ Millions)

Figure 63. China Antidote Market Size 2021-2026 ($ Millions)

Figure 64. Japan Antidote Market Size 2021-2026 ($ Millions)

Figure 65. Korea Antidote Market Size 2021-2026 ($ Millions)

Figure 66. Southeast Asia Antidote Market Size 2021-2026 ($ Millions)

Figure 67. India Antidote Market Size 2021-2026 ($ Millions)

Figure 68. Australia Antidote Market Size 2021-2026 ($ Millions)

Figure 69. Germany Antidote Market Size 2021-2026 ($ Millions)

Figure 70. France Antidote Market Size 2021-2026 ($ Millions)

Figure 71. UK Antidote Market Size 2021-2026 ($ Millions)

Figure 72. Italy Antidote Market Size 2021-2026 ($ Millions)

Figure 73. Russia Antidote Market Size 2021-2026 ($ Millions)

Figure 74. Spain Antidote Market Size 2021-2026 ($ Millions)

Figure 75. Egypt Antidote Market Size 2021-2026 ($ Millions)

Figure 76. South Africa Antidote Market Size 2021-2026 ($ Millions)

Figure 77. Israel Antidote Market Size 2021-2026 ($ Millions)

Figure 78. Turkey Antidote Market Size 2021-2026 ($ Millions)

Figure 79. GCC Country Antidote Market Size 2021-2026 ($ Millions)